Skip to main content
Erschienen in: Virology Journal 1/2015

Open Access 01.12.2015 | Short report

Differential expression of microRNAs in porcine parvovirus infected porcine cell line

verfasst von: Xinqiong Li, Ling Zhu, Xiao Liu, Xiangang Sun, Yuanchen Zhou, Qiaoli Lang, Ping Li, Yuhan Cai, Xiaogai Qiao, Zhiwen Xu

Erschienen in: Virology Journal | Ausgabe 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Porcine parvovirus (PPV), a member of the Parvoviridae family, causes great economic loss in the swine industry worldwide. MicroRNAs (miRNAs) are a class of non-protein–coding genes that play many diverse and complex roles in viral infections.

Finding

Aiming to determine the impact of PPV infections on the cellular miRNAome, we used high-throughput sequencing to sequence two miRNA libraries prepared from porcine kidney 15 (PK-15) cells under normal conditions and during PPV infection. There was differential miRNA expression between the uninfected and infected cells: 65 miRNAs were upregulated and 128 miRNAs were downregulated. We detected the expression of miR-10b, miR-20a, miR-19b, miR-181a, miR-146b, miR-18a, and other previously identified immune-related miRNAs. Gene Ontology analysis and KEGG function annotations of the host target genes suggested that the miRNAs are involved in complex cellular pathways, including cellular metabolic processes, immune system processes, and gene expression.

Conclusions

These data suggest that a large group of miRNAs is expressed in PK-15 cells and that some miRNAs were altered in PPV-infected PK-15 cells. A number of microRNAs play an important role in regulating immune-related gene expression. Our findings should help with the development of new control strategies to prevent or treat PPV infections in swine.
Hinweise
Xinqiong Li and Ling Zhu contributed equally to this work.

Competing interest

The authors declare that they have no potential conflicts of interest.

Authors’ contributions

Conception and design of the experiments: XQL, LZ, ZWX, YCZ, XGS; Experimental work: XQL; PL; YHC; XGQ; QLL; Data analysis: XQL; YHC; YCZ; manuscript preparation: XQL. All authors read and approved the final manuscript.

Background

Porcine parvovirus (PPV) is a major cause of reproductive failure in swine (Sus scrofa, ssc), where infection is characterized by early embryonic death, stillbirths, fetal death, and delayed return to estrus [1]. Additionally, PPV is associated with porcine postweaning multisystemic wasting syndrome (PMWS) and diarrhea, skin disease, and arthritis in swine [1, 2]. Even though inactivated and attenuated vaccines are widely used, the PPV-associated diseases nevertheless cause serious economic losses to the swine industry worldwide [3]. As virus replication is highly dependent on the host cell, cellular microRNA (miRNA) modification of the complex cellular regulatory networks can greatly influence viral reproduction and pathogenesis. Therefore, determining the consequences of PPV infections on cellular gene regulatory networks is urgent.
miRNAs are involved in post-transcriptional regulation of gene expression in animals, plants, and some DNA viruses. miRNAs act as regulators, inhibiting the expression of specific mRNAs by recognizing partial complementary sites in a targeted mRNA, typically within the 3’ untranslated region (3’UTR). miRNAs perform critical functions in diverse biological processes, including proliferation, apoptosis, and cell differentiation [4]. It has been well established that miRNAs play many complex roles during viral infection [5]. Therefore, an increasing number of researchers have focused on the relationship between viruses and miRNAs.
As far as we know, knowledge on the role of miRNAs in PPV infection is lacking. In this study, we detected the miRNAs expressed in porcine kidney 15 (PK-15) cells following PPV infection using high-throughput sequencing.

Methods

We used the PPV-SC-L strain, stored at the Key Laboratory of Animal Diseases and Human Health of Sichuan Province, China, in this study. PK-15 cell cultures that were 50 % confluent were infected with PPV at 10 plaque-forming units (PFU) per cell. PK-15 cells inoculated with DMEM were maintained as uninfected control cells. Cells were harvested at 24 h post-infection [6]. The cultures for each group were performed in triplicate. The infected and uninfected cells were mixed separately and used for RNA extraction. Cell viability is not affected during timecourse of infection.
Total RNA from infected PK-15 cells and normal PK-15 cells was extracted using TRIzol (Invitrogen) according to the manufacturer’s instructions. RNA quality was assessed by formaldehyde/agarose gel electrophoresis and was quantified using a ND-1000 NanoDrop Spectrophotometer (Thermo Scientific, Wilmington, MA, USA). Approximately 20 μg total RNA was subjected to Kangcheng Bio-tech inc (Shanghai, China) for Solexa sequencing of miRNAs. The same RNA was used for qRT-PCR.
RT was performed as previously described [6]. Real-time PCR was performed using SYBR Green Real-time qPCR Master Mix (Arraystar, Rockville, MD, USA) on a ViiA 7 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) according to the manufacturer’s instructions. The amplification conditions were as follows: 95 °C for 10 min, followed by 40 cycles of 95 °C for 10 s and 60 °C for 60 s. Table 1 lists the primers used. All samples were assayed in triplicate. The cycle threshold (Ct) values were analyzed using the 2-∆∆Ct method. The U6 gene was used as the internal control.
Table 1
RT-qPCR primers
Gene
RT primer
 U6
5’CGCTTCACGAATTTGCGTGTCAT3’
 miR-RT Primer
5’GTCGGTGTCGTGGAGTCGTTTGCAATTGCACTGGATTTTTTTTTTTTTTTTTTV3’
V = A, G, C
Gene
Forward primer (5’–3’)
Reversed primer (5’–3’)
 ssc-miR-10b
TACCCTGTAGAACCGAATTTGT
GTCGGTGTCGTGGAGTCG
 ssc-miR-30a-5p
TGTAAACATCCTCGACTGGAAG
GTCGGTGTCGTGGAGTCG
 ssc-miR-16
TAGCAGCACGTAAATATTGGC
GTCGGTGTCGTGGAGTCG
 ssc-miR-17-5p
CAAAGTGCTTACAGTGCAGGTAG
GTCGGTGTCGTGGAGTCG
 ssc-miR-192
CTGACCTATGAATTGACA
GTCGGTGTCGTGGAGTCG
 ssc-miR-21
TAGCTTATCAGACTGATGTTGA
GTCGGTGTCGTGGAGTCG
 ssc-miR-19b
TGTGCAAATCCATGCAAAAC
GTCGGTGTCGTGGAGTCG
 ssc-miR-18a
TAAGGTGCATCTAGTGCAGATA
GTCGGTGTCGTGGAGTCG
 ssc-miR-152
TCAGTGCATGACAGAACTTGG
GTCGGTGTCGTGGAGTCG
 ssc-miR-novel-chr13_10861
TTCAAGTAACCCAGGATAGGCT
GTCGGTGTCGTGGAGTCG
 U6
TCGCTTTGGCAGCACCTAT
AATATGGAACGCTTCGCAAA
MiRanda and TargetScan were used to predict the targets of the differentially expressed miRNAs. Predicted miRNA targets were functionally annotated through the cell component, biological process, and molecular function information supported by GO analysis. GO analysis and KEGG pathway analyses were performed using DAVID (http://​david.​abcc.​ncifcrf.​gov/​) with default parameters [7].

Results

We obtained 3,575,737 and 617,535 high-quality reads from the normal and infected cell samples, respectively, remained for miRNA analysis. The length distribution of the high-quality reads ranged 16–30 nt. Most sequence reads ranged 21–24 nt, which belonged to the typical size range (Fig. 1). We identified 533 and 286 porcine miRNAs in normal PK-15 cells and infected PK-15 cells, respectively. This indicates that the normal cells contained more miRNAs than the infected cells. The change of expression of miRNAs between normal and infected PK-15 cells reflects that miRNAs can play key roles during the viral infection process, where virus can affect cellular miRNAs expression profile on their own benefit. ssc-miR-21 was the most abundantly expressed miRNA, followed by ssc-miR-30a-5p. miRNAs were considered differentially expressed when the fold change (FC) difference between groups was >2 or ≤0.5 and P ≤ 0.01, or when a miRNA was not expressed in either the infected or control group. There were 193 differentially expressed miRNAs; 128 were downregulated and 65 were upregulated. The most upregulated and downgulated miRNA were ssc-miR-10b (36-fold) and ssc-miR-18a (0.01-fold) (Table 2).
Table 2
Top 50 miRNAs significantly up- or downregulated in PK-15 cells in order of fold change (FC)
Annotation
Normalized read counts
length
type
FC
Number of target genes
infected
control
ssc-miR-10b
42,588
1162
22
Up
36.35
738
ssc-miR-192
3769
102
21
Up
33.74
718
ssc-miR-20a
2432
116
22
Up
19.38
1490
ssc-miR-296-3p
195
3
21
Up
15.77
1863
ssc-miR-novel-chr17-18987
195
3
19
Up
15.77
1864
ssc-miR-92b-3p
2215
133
22
Up
15.56
1757
ssc-miR-30a-5p
98,034
6320
22
Up
15.49
1147
ssc-miR-novel-chr12-7961
1886
191
22
Up
9.43
1357
ssc-miR-novel-chr14-13888
582
58
23
Up
8.71
1368
ssc-miR-34a
358
37
22
Up
7.83
1663
ssc-miR-novel-chr16-17559
55
0
22
Up
6.5
1610
ssc-miR-novel-JH11865-1-42
55
0
23
Up
6.5
1727
ssc-miR-17-5p
2868
438
23
Up
6.42
1443
ssc-miR-16
11,873
1891
22
Up
6.25
1763
ssc-miR-22-3p
2267
365
22
Up
6.07
1487
ssc-miR-146b
75
3
21
Up
6.07
1139
ssc-miR-155-5p
426
62
22
Up
6.06
1146
ssc-miR-novel-chr2-20965
52
1
23
Up
5.64
1147
ssc-miR-novel-chrx-40705
758
147
22
Up
4.89
811
ssc-miR-221-3p
758
147
22
Up
4.89
811
ssc-miR-301
114
17
23
Up
4.59
1509
ssc-miR-191
741
156
23
Up
4.52
695
ssc-miR-novel-chr6-31692
46
3
22
Up
4.30
2019
ssc-miR-181a
637
147
24
Up
4.12
1221
ssc-miR-18a
88
9541
22
Down
0.0102
995
ssc-miR-novel-chr9-37990
20
1752
23
Down
0.0170
1512
ssc-miR-novel-chr9-39041
20
1752
23
Down
0.0170
1512
ssc-miR-novel-chr6-30729
13
1317
22
Down
0.0173
1083
ssc-miR-424-5p
33
2182
22
Down
0.0196
1817
ssc-miR-31
55
3118
22
Down
0.0208
1149
ssc-miR-novel-chrX-41190
0
431
21
Down
0.0227
335
ssc-miR-novel-chr11-6750
7
547
18
Down
0.0305
1406
ssc-miR-152
332
9880
21
Down
0.0346
1161
ssc-miR-542-5p
0
277
21
Down
0.0348
732
ssc-miR-499-5p
7
472
21
Down
0.0353
974
ssc-miR-142-3p
0
238
22
Down
0.0403
887
ssc-miR-135
0
235
23
Down
0.0408
1602
ssc-miR-194a
13
541
21
Down
0.0417
842
ssc-miR-361-5p
20
704
22
Down
0.0420
867
ssc-miR-185
59
1621
22
Down
0.0423
2285
ssc-miR-193a-5p
0
201
22
Down
0.0474
1142
ssc-miR-novel-chr5-29676
0
199
23
Down
0.0478
1066
ssc-miR-183
156
3132
23
Down
0.0528
1087
ssc-miR-29c
16
366
22
Down
0.0691
1120
ssc-miR-novel-chr5-29857
42
736
19
Down
0.0697
1711
ssc-miR-29a
267
3939
23
Down
0.0701
1079
ssc-miR-19a
498
6339
23
Down
0.0800
1436
ssc-miR-19b
1161
14,587
23
Down
0.0802
1299
ssc-miR--novel-chr13_10861
169
1483
22
Down
0.1199
857
ssc-miR-21
52,611
382,830
22
Down
0.1374
789
We selected 10 miRNAs to confirm the deep sequencing data. The expression levels of ssc-miR-10b, ssc-miR-30a-5p, ssc-miR-16, ssc-miR-17-5p, and ssc-miR-192 in the PPV-infected cells were higher than in the uninfected cells, whereas ssc-miR-21, ssc-miR-19b, ssc-miR-18a, ssc-miR-152, and ssc-miR-novel-chr13_10861 were downregulated compared to the uninfected cells (Fig. 2). The results were consistent with that of the deep sequencing analysis. In addition, reverse transcription–quantitative PCR (RT-qPCR) indicated the reliability of the deep sequencing data.
In our study, a total 3254 target genes were predicted for the 193 differentially expressed miRNAs. We successfully annotated about 2867 target genes through GO analysis. The upregulated biological process–related genes were involved in cellular process, metabolic process and biological regulation. The biological roles of the downregulated genes were cellular process, metabolic process, and biological regulation. GO enrichment analysis determined functional enrichment of upregulated and downregulated genes in cellular process and cell part and binding (Table 3). The target genes were classified according to Kyoto Encyclopedia of Genes and Genomes (KEGG) function annotations, and we identified pathways actively regulated by the miRNAs during PPV infection (Table 4). Some of the target genes were involved in immunity and virus infection.
Table 3
GO analysis of swine target genes. The table shows the GO annotation of the upregulated gene (A) and downregulated gene (B) in biological process, cellular component and molecular function. Ten GO terms for each process are listed
GO.ID
Term
Count
P-value
Biological process
 GO:0009987
cellular process
1782
1.0102E-05
 GO:0008152
metabolic process
1350
2.44953E-27
 GO:0065007
biological regulation
1260
0.000424577
 GO:0044238
primary metabolic process
1231
5.99319E-26
 GO:0044237
cellular metabolic process
1221
1.70495E-28
 GO:0050789
regulation of biological process
1192
0.002408788
 GO:0050794
regulation of cellular process
1147
0.000216533
 GO:0002376
immune system process
273
1.35305E-08
 GO:0006955
immune response
163
1.37682E-05
 GO:0000165
MAPK cascade
79
3.28195E-05
 Cellular Component
 GO:0044464
cell part
1772
1.04304E-42
 GO:0005623
cell
1772
1.25735E-42
 GO:0005622
intracellular
1589
1.48695E-38
 GO:0044424
intracellular part
1512
9.75601E-38
 GO:0043226
organelle
1258
3.15768E-22
 GO:0043229
intracellular organelle
1255
5.59497E-22
 GO:0005737
cytoplasm
1146
1.88382E-25
 GO:0043227
membrane-bounded organelle
1131
3.1329E-23
 GO:0043231
intracellular membrane-bounded organelle
1129
3.31685E-23
 GO:0044444
cytoplasmic part
886
1.59538E-15
 Molecular Function
 GO:0005488
binding
1781
7.2806E-35
 GO:0005515
protein binding
1406
1.01651E-30
 GO:0003824
catalytic activity
791
4.12422E-11
 GO:0043167
ion binding
425
2.86598E-07
 GO:0043169
cation binding
423
3.71961E-07
 GO:0046872
metal ion binding
416
4.07808E-07
 GO:0003676
nucleic acid binding
368
0.010086661
 GO:0036094
small molecule binding
366
1.33205E-09
 GO:0000166
nucleotide binding
341
4.24208E-09
 GO:0097159
organic cyclic compound binding
341
4.47117E-09
 B
 Biological Process
 GO:0009987
cellular process
1732
0.000468457
 GO:0008152
metabolic process
1280
0.000101041
 GO:0065007
biological regulation
1226
0.039474247
 GO:0044238
primary metabolic process
1179
0.011728824
 GO:0044237
cellular metabolic process
1153
0.011728824
 GO:0050789
regulation of biological process
1150
0.022891558
 GO:0050794
regulation of cellular process
1100
0.023393923
 GO:0002376
immune system process
265
3.49438E-08
 GO:0006955
immune response
161
7.5883E-06
 GO:0022402
cell cycle process
151
0.001985807
 Cellular Component
 GO:0044464
cell part
1699
1.61069E-32
 GO:0005623
cell
1699
1.89406E-32
 GO:0005622
intracellular
1506
1.8551E-26
 GO:0044424
intracellular part
1426
4.89384E-25
 GO:0043226
organelle
1212
8.24637E-20
 GO:0043229
intracellular organelle
1208
2.30659E-19
 GO:0043227
membrane-bounded organelle
1089
8.12018E-21
 GO:0043231
intracellular membrane-bounded organelle
1088
5.50768E-21
 GO:0005737
cytoplasm
1079
5.97213E-18
 GO:0044444
cytoplasmic part
836
2.48602E-11
 Molecular Function
 GO:0005488
binding
1748
3.63499E-36
 GO:0005515
protein binding
1408
1.06202E-38
 GO:0003824
catalytic activity
743
5.00132E-07
 GO:0043167
ion binding
410
2.18765E-06
 GO:0043169
cation binding
408
2.81762E-06
 GO:0046872
metal ion binding
400
4.31756E-06
 GO:0003676
nucleic acid binding
365
0.004482893
 GO:0036094
small molecule binding
335
6.20944E-06
 GO:0000166
nucleotide binding
309
2.81002E-05
 GO:0097159
organic cyclic compound binding
309
2.91504E-05
Table. 4
Target genes of 17 differentially expressed miRNAs involved in immune response pathways
KEGG pathways
Target genes
Differentially expressed microRNAs
FDR
T cell receptor signaling pathway
CTLA4, FYN, IKBKG, NFATC2, NCK1, CD8A, PIK3CG, CDC42, PTPN6, CD4, CD40LG, ICOS, PIK3R5, MAPK14, TNF, MAP3K7
miR-10b, miR-9, miR-30a-5p, miR-17-5p, miR-16, miR-18a, miR-19b, miR-20a, miR-19a, miR-122, miR-146b, miR-55-5p, miR-181a, miR-196b, let-7 g, let-7c
8.89308E-12
Toll-like receptor signaling pathway
CTSK, TLR7, MAP3K7, MAPK14, CXCL9, PIK3CG, NFKB1, CD40, STAT1, IL12B, CD86, IL6
miR-10b, miR-9, miR-30a-5p, miR-17-5p, miR-16, miR-18a, miR-19b, miR-20a, miR-21, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, miR-196b, let-7 g, let-7c
1.04578E-07
NF-kappaB signaling pathway
MAP3K7, CXCL12, DDX58, LCK, XIAP, ATM, VCAM1, NFKB1, TNF, CD40LG
miR-10b, miR-9, miR-30a-5p, miR-17-5p, miR-16, miR-18a, miR-19b, miR-20a, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, miR-196b
1.18108E-06
RIG-I-like receptor signaling pathway
MAP3K7, MAPK14, DHX58, DDX58, IKBKG, TANK, IKBKB, DDX3X, NFKB1, TNF, IL12B
miR-10b, miR-9, miR-30a-5p, miR-17-5p, miR-16, miR-18a, miR-19b, miR-21, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, let-7c
1.70355E-05
Jak-STAT signaling pathway
JAK2, STAT4, STAT5B, JAK3, PIK3CG, PIM1, PTPN6, TYK2, MAPK14, STAT4, STAT1, IL7R, IL12B, IL6, PIK3R5, MYC
miR-9, miR-17-5p, miR-16, miR-18a, miR-19b, miR-20a, miR-21, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, miR-196b, let-7 g, let-7c
0.000124339
NOD-like receptor signaling pathway
MAP3K7, MAPK14, IKBKG, IKBKB, NFKB1, TNF, IL6
miR-10b, miR-9, miR-17-5p, miR-16, miR-18a, miR-19b, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, let-7 g, let-7c
0.001546381

Discussion and conclusion

Previous studies have shown that viruses have evolved a wide variety of means for resisting the host immune system [810]. Furthermore, miRNAs play important roles in controlling immune regulation, including cellular differentiation and immune response [1113]. Identifying and probing miRNAs in the immune system is important for understanding their physiological and pathological roles in PPV infection. In this study, we used high-throughput sequencing to identify miRNAs.
Recent studies have provided compelling evidence that cellular miRNAs play an important role in host defense against virus infection [14]. Many immune-related miRNAs have been identified in innate and adaptive immune systems, including the miR-17—92 cluster, miR-221, miR-10, miR-196b, miR-126, miR-155, miR-150; miR-181a, miR-326, miR-142-3p, miR-424, miR-21, miR-106a, miR-223, miR-146; the let-7 family, miR-9, and miR-34 [6]. We found many differentially expressed miRNAs in the normal and PPV-infected PK-15 cells. Among them, let-7 g, miR-17-5p, miR-17-3p, miR-20a, miR-181a, miR-16, miR-146b, miR-10b, and miR-155-5p were upregulated; let-7c, miR-122, miR-18a, miR-19a, miR-19b, miR-196b, miR-21, and miR-9 were downregulated. These data suggest that viral mechanisms can affect host miRNA expression. However, we did not detect differential expression of other previously identified miRNAs (miR-223, miR-150, miR-92a), although miR-10b, miR-20a, miR-30a-5p, miR-34a, miR-17—5p, miR-16, miR-146b, and miR-155-5p expression was significantly different. In contrast, expression of the downregulated immune-related miRNAs was not significantly different, except miR-18a, miR-19b, and miR-21. This suggests that miRNAs play an important role in the coordinated regulation of immune-related gene expression in PK-15 cells in response to PPV infection.
miR-21, which had high read numbers in both normal and PPV-infected cells, was downregulated; it is related to immune response and virus replication [15]. Moreover, it is a negative regulator of toll-like receptor 4 (TLR4) signaling by targeting programmed cell death 4 (PDCD4) [16]. miR-19b and miR-18a expression was downregulated in the infected cells, suggesting that they play a negative role in PPV replication. Although viruses may downregulate host miRNA by suppressing Dicer expression, the mechanism of downregulation remains unclear [17]. Therefore, future studies are necessary for investigating the mechanism of PPV downregulation of cellular miRNA.
miR-10 expression was upregulated in the infected cells. Mitogen-activated protein kinase kinase kinase 7 (MAP3K7), considered a target gene of miR-10, regulates the inhibitor of nuclear factor κB/nuclear factor κB (IκB/NF-κB) signaling pathway [18]. In addition, miR-10 controls brain-derived neurotrophic factor (BDNF) levels via the miRNA–mRNA regulatory network [19]. We surmise that a possible function of miR-10 in triggering an antiviral response is targeting the MAP3K7 and BDNF genes. The miR-30 family is involved in various biological and pathological processes. For example, miR-30a may be involved in B cell hyperactivity [20]. We detected miR-10 and miR-30 in this study, suggesting that they are related to the cellular immune response to PPV infection.
GO analysis showed that many of the identified miRNAs found in other studies were predicted to participate in immunity [21]. Many genes, including MAP3K7, IRAK1, TLR7, CD40, TGFBR1, RPS6KA3, IGF1R, CDC37, ITGA4, CBLB, ITGA5, IL7, ATM, DPP8, MAPK14, CD2, WNT2B, CAV1, and CD96, are involved in the immune-related programs. KEGG analysis showed that these targeted genes could participate in multiple signaling pathways, including that for retinoic acid–inducible gene-I (RIG-I)-like receptor, TLRs, Janus kinase–signal transducer and activator of transcription (JAK–STAT), and T-cell receptor. Interleukin 10 (IL10) plays an important role in virus infection by inhibiting several proinflammatory cytokines [22]. Let-7 g, let-7c, miR-19b, and miR-16 are involved in immune-related programs and may act through the target gene IL10. These results suggest that miRNAs participate in the regulation of piglet immunity. It has been established that miRNAs can target specific genes [23]; in the present study, let-7c, let-7 g, miR-18a, miR-196b, and miR-9 targeted MAP3K7, and miR-196b and miR-19b targeted dipeptidyl-peptidase 8 (DPP8), suggesting that cellular miRNAs play a key role in regulating gene expression in response to PPV infection. Genes targeted by miRNAs are involved in immune response–associated pathways in human parvovirus B19 infection [24]. We speculate that host miRNAs relate to common immune pathways in response to parvovirus infection.
To our knowledge, this is first study to survey the miRNA expression profiles in PPV-infected PK-15 cells through high-throughput sequencing. A number of miRNAs detected were previously described as immune system regulators. Target analysis confirmed that these miRNAs played an important role in PPV infection. These findings contribute to our understanding of the roles miRNAs play in host–pathogen interactions and help with the development of new control strategies to prevent or treat PPV infections in swine.

Acknowledgments

This study was supported by the Program for New Century Excellent Talents in University of Ministry of Education of China (Project No: NCET-11-1059), and by the Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University (04310734). miRNA sequencing services were provided by KangChen Bio-tech, Shanghai, China.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interest

The authors declare that they have no potential conflicts of interest.

Authors’ contributions

Conception and design of the experiments: XQL, LZ, ZWX, YCZ, XGS; Experimental work: XQL; PL; YHC; XGQ; QLL; Data analysis: XQL; YHC; YCZ; manuscript preparation: XQL. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Allan G, Kennedy S, McNeilly F, Foster J, Ellis J, Krakowka S, et al. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J Comp Pathol. 1999;121:1–11.CrossRefPubMed Allan G, Kennedy S, McNeilly F, Foster J, Ellis J, Krakowka S, et al. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J Comp Pathol. 1999;121:1–11.CrossRefPubMed
2.
Zurück zum Zitat Ellis J, Bratanich A, Clark E, Allan G, Meehan B, Haines D, et al. Coinfection by porcine circoviruses and porcine parvovirus in pigs with naturally acquired postweaning multisystemic wasting syndrome. J Vet Diagn Invest. 2000;12:21–7.CrossRefPubMed Ellis J, Bratanich A, Clark E, Allan G, Meehan B, Haines D, et al. Coinfection by porcine circoviruses and porcine parvovirus in pigs with naturally acquired postweaning multisystemic wasting syndrome. J Vet Diagn Invest. 2000;12:21–7.CrossRefPubMed
3.
Zurück zum Zitat Opriessnig T, Fenaux M, Yu S, Evans R, Cavanaugh D, Gallup J, et al. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus. Vet Microbiol. 2004;98:209–20.CrossRefPubMed Opriessnig T, Fenaux M, Yu S, Evans R, Cavanaugh D, Gallup J, et al. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus. Vet Microbiol. 2004;98:209–20.CrossRefPubMed
4.
Zurück zum Zitat Sun W, Julie Li Y-S, Huang H-D, Shyy JY, Chien S. microRNA: a master regulator of cellular processes for bioengineering systems. Annu Rev Biomed Eng. 2010;12:1–27.CrossRefPubMed Sun W, Julie Li Y-S, Huang H-D, Shyy JY, Chien S. microRNA: a master regulator of cellular processes for bioengineering systems. Annu Rev Biomed Eng. 2010;12:1–27.CrossRefPubMed
5.
Zurück zum Zitat Hicks JA, Yoo D, Liu H-C. Characterization of the microRNAome in Porcine Reproductive and Respiratory Syndrome Virus Infected Macrophages. PLoS One. 2013;8:e82054.CrossRef Hicks JA, Yoo D, Liu H-C. Characterization of the microRNAome in Porcine Reproductive and Respiratory Syndrome Virus Infected Macrophages. PLoS One. 2013;8:e82054.CrossRef
6.
Zurück zum Zitat Cai Y, Zhu L, Zhou Y, Liu X, Li X, Lang Q, et al. Identification and Analysis of Differentially-Expressed microRNAs in Japanese Encephalitis Virus-Infected PK-15 Cells with Deep Sequencing. Int J Mol Sci. 2015;16:2204–19.PubMedCentralCrossRefPubMed Cai Y, Zhu L, Zhou Y, Liu X, Li X, Lang Q, et al. Identification and Analysis of Differentially-Expressed microRNAs in Japanese Encephalitis Virus-Infected PK-15 Cells with Deep Sequencing. Int J Mol Sci. 2015;16:2204–19.PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1–13.PubMedCentralCrossRef Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1–13.PubMedCentralCrossRef
8.
Zurück zum Zitat Alcami A. Structural basis of the herpesvirus M3–chemokine interaction. Trends Microbiol. 2003;11:191–2.CrossRefPubMed Alcami A. Structural basis of the herpesvirus M3–chemokine interaction. Trends Microbiol. 2003;11:191–2.CrossRefPubMed
10.
Zurück zum Zitat Katze MG, He Y, Gale M. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002;2:675–87.CrossRefPubMed Katze MG, He Y, Gale M. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002;2:675–87.CrossRefPubMed
11.
Zurück zum Zitat Thai T-H, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, et al. Regulation of the germinal center response by microRNA-155. Science. 2007;316:604–8.CrossRefPubMed Thai T-H, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, et al. Regulation of the germinal center response by microRNA-155. Science. 2007;316:604–8.CrossRefPubMed
12.
Zurück zum Zitat Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007;316:608–11.PubMedCentralCrossRefPubMed Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007;316:608–11.PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008;451:1125–9.CrossRefPubMed Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008;451:1125–9.CrossRefPubMed
14.
Zurück zum Zitat Song L, Liu H, Gao S, Jiang W, Huang W. Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Viro. 2010;84:8849–60.CrossRef Song L, Liu H, Gao S, Jiang W, Huang W. Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Viro. 2010;84:8849–60.CrossRef
15.
Zurück zum Zitat Lu TX, Hartner J, Lim EJ, Fabry V, Mingler MK, Cole ET, et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol. 2011;187:3362–73.PubMedCentralCrossRefPubMed Lu TX, Hartner J, Lim EJ, Fabry V, Mingler MK, Cole ET, et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol. 2011;187:3362–73.PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Coll RC, O’Neill LA. New insights into the regulation of signalling by toll-like receptors and nod-like receptors. J Innate Immun. 2010;2:406–21.CrossRefPubMed Coll RC, O’Neill LA. New insights into the regulation of signalling by toll-like receptors and nod-like receptors. J Innate Immun. 2010;2:406–21.CrossRefPubMed
17.
Zurück zum Zitat Grinberg M, Gilad S, Meiri E, Levy A, Isakov O, Ronen R, et al. Vaccinia virus infection suppresses the cell microRNA machinery. Arch Virol. 2012;157:1719–27.CrossRefPubMed Grinberg M, Gilad S, Meiri E, Levy A, Isakov O, Ronen R, et al. Vaccinia virus infection suppresses the cell microRNA machinery. Arch Virol. 2012;157:1719–27.CrossRefPubMed
18.
Zurück zum Zitat Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci. 2010;107:13450–5.PubMedCentralCrossRefPubMed Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci. 2010;107:13450–5.PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Muller S. In silico analysis of regulatory networks underlines the role of miR-10b-5p and its target BDNF in huntington’s disease. Translational neurodegeneration. 2014;3:17.PubMedCentralCrossRefPubMed Muller S. In silico analysis of regulatory networks underlines the role of miR-10b-5p and its target BDNF in huntington’s disease. Translational neurodegeneration. 2014;3:17.PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Liu Y, Dong J, Mu R, Gao Y, Tan X, Li Y, et al. MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn. Arthritis Rheum. 2013;65:1603–11.CrossRefPubMed Liu Y, Dong J, Mu R, Gao Y, Tan X, Li Y, et al. MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn. Arthritis Rheum. 2013;65:1603–11.CrossRefPubMed
21.
22.
23.
Zurück zum Zitat Zhou A, Li S, Wu J, Khan FA, Zhang S. Interplay between microRNAs and host pathogen recognition receptors (PRRs) signaling pathways in response to viral infection. Virus Res. 2014;184:1–6.CrossRefPubMed Zhou A, Li S, Wu J, Khan FA, Zhang S. Interplay between microRNAs and host pathogen recognition receptors (PRRs) signaling pathways in response to viral infection. Virus Res. 2014;184:1–6.CrossRefPubMed
24.
Zurück zum Zitat Kühl U, Rohde M, Lassner D, Gross U, Escher F, Schultheiss H-P. miRNA as activity markers in Parvo B19 associated heart disease. Herz. 2012;37:637–43.CrossRefPubMed Kühl U, Rohde M, Lassner D, Gross U, Escher F, Schultheiss H-P. miRNA as activity markers in Parvo B19 associated heart disease. Herz. 2012;37:637–43.CrossRefPubMed
Metadaten
Titel
Differential expression of microRNAs in porcine parvovirus infected porcine cell line
verfasst von
Xinqiong Li
Ling Zhu
Xiao Liu
Xiangang Sun
Yuanchen Zhou
Qiaoli Lang
Ping Li
Yuhan Cai
Xiaogai Qiao
Zhiwen Xu
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
Virology Journal / Ausgabe 1/2015
Elektronische ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-015-0359-4

Weitere Artikel der Ausgabe 1/2015

Virology Journal 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Innere Medizin

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Krebspatienten impfen: Was? Wen? Und wann nicht?

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Nierenultraschall: Tipps vom Profi

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

„KI sieht, was wir nicht sehen“

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.